Literature DB >> 14557462

Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.

Ronald N Cohen1, Laurie E Cohen, Diego Botero, Christine Yu, Angela Sagar, Magdalena Jurkiewicz, Sally Radovick.   

Abstract

HESX1 is a paired-like homeodomain transcription factor that functions as a repressor of PROP1-mediated gene stimulation. Mutations in HESX1 have been implicated in cases of septooptic dysplasia and congenital hypopituitarism. All mutations in HESX1 identified to date have resulted in impaired DNA binding and defective HESX1 action. We have identified a novel HESX1 mutation in genomic nucleotide position 1684 (g.1684delG), which results in a mutant protein with increased DNA binding. In turn, this mutation causes increased repression of PROP1-dependent gene activity. These data suggest that enhancement of transcriptional repression during pituitary organogenesis is a novel mechanism for the development of congenital pituitary disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557462     DOI: 10.1210/jc.2002-021868

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

Review 1.  Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Surv Ophthalmol       Date:  2013 Nov-Dec       Impact factor: 6.048

Review 2.  Septo-optic dysplasia.

Authors:  Emma A Webb; Mehul T Dattani
Journal:  Eur J Hum Genet       Date:  2009-07-22       Impact factor: 4.246

3.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

4.  HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.

Authors:  Qing Fang; Anna Flavia Figueredo Benedetti; Qianyi Ma; Louise Gregory; Jun Z Li; Mehul Dattani; Abdollah Sadeghi-Nejad; Ivo J P Arnhold; Berenice Bilharinho Mendonca; Sally A Camper; Luciani R Carvalho
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-28       Impact factor: 3.478

5.  A novel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression.

Authors:  Aurore Carré; Rasha T Hamza; Dulanjalee Kariyawasam; Loïc Guillot; Raphaël Teissier; Elodie Tron; Mireille Castanet; Corinne Dupuy; Mohamed El Kholy; Michel Polak
Journal:  Thyroid       Date:  2014-01-23       Impact factor: 6.568

Review 6.  Molecular defects in the growth hormone-IGF axis.

Authors:  Joyce Lee; Ram K Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

7.  A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain.

Authors:  Xinsheng Lai; Xianyong Lan; Hong Chen; Xinlei Wang; Keyi Wang; Mou Wang; Hui Yu; Miao Zhao
Journal:  Mol Biol Rep       Date:  2008-10-14       Impact factor: 2.316

8.  Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.

Authors:  G Corneli; D Vivenza; F Prodam; G Di Dio; A Vottero; A Rapa; S Bellone; S Bernasconi; G Bona
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

9.  Unusual phenotypic features in a patient with a novel splice mutation in the GHRHR gene.

Authors:  Latifa Hilal; Yassir Hajaji; Marie-Pierre Vie-Luton; Zeina Ajaltouni; Bouchra Benazzouz; Maha Chana; Adelmajid Chraïbi; Abdelkrim Kadiri; Serge Amselem; Marie-Laure Sobrier
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  Effects of genetic variability of the caprine homeobox transcription factor HESX1 gene on performance traits.

Authors:  Xianyong Lan; Xinsheng Lai; Zhuanjian Li; Jing Wang; Chuzhao Lei; Hong Chen
Journal:  Mol Biol Rep       Date:  2009-07-23       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.